This study evaluated the immunogenicity of the Bacillus Calmette-Guérin (BCG) vaccine in a guinea pig model to refine preclinical assessment methods. 24 guinea pigs were divided into four groups for immunohistochemical, histopathological, and molecular analyses, including qRT-PCR and ELISA. The ELISA results revealed significant elevations in interleukin 2 (IL-2), interferon-gamma (IFN- ), and tuberculosis-specific antibodies in vaccinated guinea pigs, particularly γ notable after 6 weeks. Although lung cytokine levels remained unchanged, spleen gene expression showed significant differences in interleukin-17, interleukin-12, interleukin-1β, and C-X-C motif chemokine ligand 10 after 6 weeks. Immunohistochemistry revealed peak IL-2 expression at 8 weeks and significant IFN-γ and TNF-α expression at 6 weeks. This study confirmed the effectiveness of BCG vaccine in guinea pigs, providing crucial insights for future tuberculosis vaccine development and standardizing immune response indicators.

We previously developed a novel attenuated Salmonella Typhimurium (S.Typhimurium) △lon△cpxR vaccine. This study was conducted in order to examine whether this vaccine could effectively protect growing piglets against Salmonella infection. Pregnant sows in group A were primed and boosted with the vaccine, whereas pregnant sows in group B received sterile PBS-sucrose. After farrowing, newborn piglets in groups A and B were challenged with a wild type virulent S. Typhimurium at three weeks of age. During the study, serum IgG titers of piglets in group A were significantly higher than those of piglets in group B (P<0.001). In addition, clinical signs were observed in 5.9% of piglets in group A during the entire experimental period after the challenge, while diarrhea was observed in 81.6% of piglets in group B. These results indicate that vaccination of the pregnant sows resulted in effective protection in piglets against Salmonella infection.

The objective of this study was to investigate the effect of a herd specific vaccine against Staphylococcus aureus (S. aureus) by different inoculation route, IMI (intramammary injection), Koso, and supramammary lymphnode area. Based on strains of S. aureus from a case of acute clinical mastitis in Daekwanryeong farm, two experimental vaccines were made, inactivated vaccine and sonicated one. To determine the antigen concentration of the vaccine, 220 ICR-mice were immunized by the intraperitoneal route with inactivated or sonicated experimental vaccines according to different schedules with 10 ICR mice as a control group. The sonicated vaccine was selected for further experiments in vaccination and the highest antibody titer in ELISA was observed at 3㎎/㎖ of the vaccine. The vaccine was administrated to 22 healthy cows at drying up. The quarter milk samples and bloods were collected before vaccination, right after parturition and 3 months postpartum. There were no significant differences among vaccination routes based on the antibody titers in serum and intramammary bacterial infections during drying up period. The antibody titer in serum of vaccinated cows was higher at parturition than 3 months postpartum but it had no statistical meaning, though decreased clinical signs and morbidity were observed. Results of this study suggest that the concept of the vaccine against S. aureus is to decreasing clinical mastitis rather than preventing the disease.